MTF Biologics Makes Key Board Appointments

EDISON, N.J.--(BUSINESS WIRE)--Apr 29, 2026--

MTF Biologics, a global nonprofit organization that saves and heals lives through tissue and organ donation, transplantation, and research, today announced the appointment of Ladora (Dorrie) A. Dils, RN, BSN, MHA, CPTC, to its Board of Directors and existing Board member, David R. McAllister, MD, as Vice Chair.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429064007/en/

“Dorrie understands the complex clinical and very personal dynamics of organ and tissue donation,” said Joe Yaccarino, MTF Biologics’ President and Chief Executive Officer. “Her expertise will be pivotal as we consider additional ways to support clinicians in saving and healing lives and as we look to further advocate for donors, donor families, and organ and tissue recipients. The addition of Dorrie to our Board, along with the appointment of David McAllister as Vice Chair, will strengthen our organization, and I’m excited to see the impact they will make.”

“We are excited to welcome Dorrie to the MTF Biologics Board,” said Dr. Donald Hackbarth, Chairman of the Board. “With experience as a healthcare provider, as well as a long history of leadership in organ donation, she brings a unique perspective to MTF Biologics that will be a great asset as we seek new ways to support the advancement of the organization’s work and Mission.”

Dils began her career as a nurse in a Level I trauma intensive care unit at Grant Medical Center in Columbus, Ohio. She transitioned into organ donation in 1991 when she joined the team at Lifeline of Ohio as a donation coordinator. She remained at Lifeline of Ohio for more than two decades, serving in many roles, including Chief Clinical Officer. Dils was named President and Chief Executive Officer of Gift of Life Michigan, the nation’s 11th-largest organ and tissue program, in 2024.

“I am excited to continue serving the organ and tissue donation community through this new appointment,” said Dorrie Dils. “MTF Biologics is a driving force in advocating for tissue donation and the impact it makes, and honoring donor families. I am thrilled to join forces with its Board and team to advance this important work.”

Dils is the Immediate Past President of the Association of Organ Procurement Organizations (AOPO), which represents 48 of the nation’s 56 organ procurement organizations throughout the United States. She also has served on the Organ Procurement and Transplantation Network’s (OPTN) Board of Directors, as Vice Chair of the University of Toledo Donation and Transplant Sciences program and as Chair of the AOPO Ethics Committee and Vice Chair of its Advocacy Committee. In addition, Dils is a former faculty member for the Health Resources and Services Administration Collaborative and a board member for the National Kidney Foundation of Ohio and the Multiple Sclerosis Society. Dils was elected Vice Chair by the MTF Biologics Donation Board of Trustees and, through that role, serves on the MTF Biologics Board of Directors.

Dils earned her bachelor's degree in nursing from Franklin University and a master’s degree in healthcare administration from Ohio University. In 2004, Business First named her one of the top “40 Under 40,” and Crain's Detroit Business named her a Notable Woman in Health in 2020 and a Health Care Hero in 2025.

McAllister joined the MTF Biologics Board of Directors in 2021 and has been a vital contributor to the organization’s Medical Board of Trustees since 2005. As a distinguished leader in orthopedic surgery, he brings a wealth of clinical expertise. His deep institutional knowledge and extensive leadership experience make him uniquely qualified to step into this role as Vice Chair.

About MTF Biologics

MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. In partnership with organ and tissue recovery organizations, MTF Biologics provides exceptional services, resources, and expertise to donors and their families; tissue and organ transplant patients; and clinicians and scientists who advance patient care.

The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized screening, coordination, and communications services to organ transplant centers, organ, tissue, and eye procurement organizations, and the hospitals and patients that they serve. Its sister organization, Deutsches Institut für Zell- und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation) expands its reach to patients across the globe.

David R. McAllister, MD

Ladora (Dorrie) A. Dils, RN, BSN, MHA, CPTC

NEW YORK (AP) — The governor of Sinaloa and nine other current and former Mexican officials were charged with drug trafficking and weapons offenses in a U.S. indictment unsealed Wednesday in New York, accused of aiding in the massive importation of illicit narcotics into the United States.

U.S. federal officials announced the charges in a news release. None of the defendants were in custody.

Those charged in Manhattan federal court are current and former government or law enforcement officials in Sinaloa, including Rubén Rocha Moya, who has been governor of Mexico's Sinaloa state since November 2021.

Rocha was a staunch ally of former President Andrés Manuel López Obrador and of his “Hugs, Not Bullets” policy, which involved avoiding direct confrontation with drug cartels.

Rocha, the highest profile official charged, said he “categorically and completely rejects” the accusations and said they were baseless. The official called the charges as an “attack” on Mexico’s ruling party and its leaders.

“It is part of a perverse strategy to violate (Mexico’s) constitutional order, specifically on national sovereignty,” he wrote in a post on X on Wednesday afternoon. “We will show them that this slander doesn’t have any sort of foundation.”

Some of those named, according to the indictment, have themselves participated in the Sinaloa Cartel's campaign of violence and retribution.

The indictment alleged that they were closely aligned with the faction of the Sinaloa Cartel, known in Mexico as the Cartel de Sinaloa, which is run by the sons of Joaquín “El Chapo” Guzmán, the ex-cartel leader now serving a life sentence in a U.S. prison.

Authorities said the defendants have played essential roles in helping the Sinaloa Cartel ship fentanyl, heroin, cocaine and methamphetamine from Mexico into the United States. The Sinaloa Cartel is among eight Latin American crime groups designated as terrorist organizations by the U.S.

In a release, U.S. Attorney Jay Clayton called the Sinaloa Cartel “a ruthless criminal organization that has flooded this community with dangerous drugs for decades.”

He added: “As the indictment lays bare, the Sinaloa Cartel, and other drug trafficking organizations like it, would not operate as freely or successfully without corrupt politicians and law enforcement officials on their payroll.”

The indictment “exposes a deliberate effort to undermine public institutions and put American lives at risk,” said Terrance Cole, the head of the U.S. Drug Enforcement Administration. The charged officials “used positions of trust to protect cartel operations, enabling a pipeline of deadly drugs into our country.”

Among those indicted, at least three officials –- Rocha, the governor, the mayor of Sinaloa’s capital, and a senator -– were affiliated with Mexican President Claudia Sheinbaum’s party, Morena. A number of other officials held positions unaffiliated with Mexican parties.

The charges come after U.S. Ambassador to Mexico Ron Johnson last week said that the U.S. administration would launch an anti-corruption campaign targeting Mexican officials he said were linked to organized crime.

"Corruption not only hinders progress, it distorts it. It increases costs, weakens competition, and erodes the trust upon which markets depend. It is not a problem without victims,” Johnson said.

Mexican President Claudia Sheinbaum responded Monday by saying that her government has not seen “any evidence” of the charges of corruption.

“Any investigation in the United States against any person in Mexico must have evidence reviewed by the (Mexican) Attorney General’s Office,” Sheinbaum said.

U.S. prosecutors previously brought drug trafficking charges against a former Mexican cabinet member, Genaro García Luna, who was accused of taking bribes to help the Sinaloa Cartel while he was supposedly combating it as his country’s public security secretary. García Luna was convicted in 2023 and was sentenced to more than 38 years in prison. He denied the allegations and is appealing his conviction.

Associated Press writers Megan Janetsky, María Verza and Fabiola Sánchez reported from Mexico City while AP writer Jennifer Peltz contributed from New York.

FILE - Sinaloa state Gov. Ruben Rocha waves as he takes part in an annual earthquake drill in Culiacan, Mexico, Sept. 19, 2024. (AP Photo/Eduardo Verdugo, File)